SCHEMBL3798734

SCHEMBL3798734

CCOC(=O)C(C(=O)c1ccc(S(C)(=O)=O)cc1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.45
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CCR5 P51681 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
PTGS1 P23219 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SCN9A Q15858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3796213 0.86 CA12 (0.48) PTGS2MEN1KMT2ACA12CA1
SCHEMBL13228066 0.86 SLC6A3 (0.47) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL6511100 0.84 PTGS2 (0.50) PTGS2SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL3809038 0.84 GAA (0.47) PTGS2ALDH1A1LMNAKMT2ACA12
SCHEMBL3797363 0.83 PTGS2 (0.45) PTGS2ALDH1A1CCR5PTGS1
SCHEMBL3796823 0.83 GAA (0.40) ALDH1A1KMT2ACA12CA1CA2
SCHEMBL3803003 0.82 CA12 (0.52) PTGS2ALDH1A1LMNAMEN1KMT2A
SCHEMBL3795486 0.82 GAA (0.48) PTGS2SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL3795965 0.81 NHERF1 (0.46) ALDH1A1KMT2ACA12CA1CA2
SCHEMBL3798133 0.81 EPHX2 (0.50) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781592-B2 Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same CJ CHEILJEDANG CORPORATION (KR) 2010-08-24 US disclosed
US-20080090875-A1 Thione Derivative, Method For The Preparation Thereof, And Pharmaceutical Composition Containing The Same CJC CORPORATION (KR) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090875-A1 Thione Derivative, Method For The Preparation Thereof, And Pharmaceutical Composition Containing The Same TPMT, TST, CYP3A5 PTGS2 922/4885SLC6A2 1291/4885SLC6A4 640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.